Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 51298-62-5 Chemical Structure| 51298-62-5

Structure of H-Arg(NO2)-OMe·HCl
CAS No.: 51298-62-5

Chemical Structure| 51298-62-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

L-NAME HCl is a non-selective NOS inhibitor with Ki values of 15 nM, 39 nM and 4.4 μM for nNOS (bovine), eNOS (human), and iNOS (murine), respectively.

Synonyms: NG-Nitroarginine methyl ester hydrochloride; L-NAME hydrochloride; H-Arg(NO2)-OMe.HCl

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of H-Arg(NO2)-OMe·HCl

CAS No. :51298-62-5
Formula : C7H16ClN5O4
M.W : 269.69
SMILES Code : O=C(OC)[C@@H](N)CCCNC(N[N+]([O-])=O)=N.[H]Cl
Synonyms :
NG-Nitroarginine methyl ester hydrochloride; L-NAME hydrochloride; H-Arg(NO2)-OMe.HCl
MDL No. :MFCD00039052
InChI Key :QBNXAGZYLSRPJK-JEDNCBNOSA-N
Pubchem ID :135193

Safety of H-Arg(NO2)-OMe·HCl

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302+H312+H332-H315-H319-H228
Precautionary Statements:P501-P261-P270-P240-P210-P241-P271-P264-P280-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330-P302+P352+P312-P304+P340+P312
Class:4.1
UN#:1325
Packing Group:

Isoform Comparison

Biological Activity

Target
  • eNOS

    eNOS, Ki:39 nM

  • iNOS

    iNOS, Ki:4.4 μM

  • nNOS

    nNOS, Ki:15 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
Human umbilical vascular endothelial cells (HUVECs) 1 mM 4 days To induce endothelial-to-mesenchymal transition (EndoMT) and study its reversibility. Results showed that the combination of L-NAME and Ang II can stimulate EndoMT in HUVECs, and this process can be reversed. Front Pharmacol. 2022 Jun 23;13:912660.
mouse aortic segments 300 µM 20 min To evaluate the involvement of the endothelial cell layer in regulating VSMC contraction and tone, L-NAME inhibits NO production, further increasing contraction. Int J Mol Sci. 2021 Nov 26;22(23):12812.
Fetal vessels 100 μM In fetal vessels, L-NAME was used along with ODQ and INDO to study ACh-induced vasodilation. Results showed that ACh-induced relaxation was significantly reduced in SD fetal vessels. Sci Rep. 2015 May 8;5:9753.
Weanling vessels 100 μM In weanling vessels, L-NAME was used along with ODQ and INDO to study ACh-induced vasodilation. Results showed that ACh-induced relaxation was significantly reduced in SD weanling vessels. Sci Rep. 2015 May 8;5:9753.
Adult vessels 100 μM In adult vessels, L-NAME was used along with ODQ and INDO to study ACh-induced vasodilation. Results showed that ACh-induced relaxation was significantly reduced in SD adult vessels. Sci Rep. 2015 May 8;5:9753.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Gastric emptying model Intraperitoneal injection 50 mg/kg Single dose L-NAME significantly delayed gastric emptying, while L-Arginine was not directly used in the experiment. Gut. 2005 Aug;54(8):1078-84
Mice Hypertension model Oral 0.5mg/mL 2 weeks L-NAME, 3 weeks high salt diet To study the role of CD70 and immunological memory in hypertension Circ Res. 2016 Apr 15;118(8):1233-43
Mice ACE 10/10 and ACE 3/3 mice Drinking water 0.5 mg/mL for WT mice, 1.5 mg/mL for mutant mice 4 weeks of L-NAME, 1-week washout, 3 weeks of high salt diet To study the development of salt sensitivity following renal injury, results showed that mice lacking renal ACE did not develop hypertension after high salt diet Hypertension. 2015 Sep;66(3):534-42
Mice EP3 receptor deficient mice Drinking water 0.5 mg/mL 2 weeks L-NAME, 2 weeks washout, 3 weeks high-salt diet To investigate the role of EP3 receptors in salt-sensitive hypertension, results showed that EP3 receptor deficient mice had significantly attenuated blood pressure elevation and renal inflammation during the salt-feeding phase. Hypertension. 2019 Dec;74(6):1507-1515
Mice Salt-sensitive hypertension model Drinking water 0.5 mg/mL 2 weeks L-NAME, 2 weeks washout, 3 weeks high-salt diet To study the role of SGK1 in CD11c+ antigen-presenting cells, finding that SGK1 deletion attenuates salt-sensitive hypertension and renal inflammation. Hypertension. 2019 Sep;74(3):555-563
Rats Chronic constriction injury model Intrathecal injection 100 μg/10 μL Once daily for 5 days L-NAME reversed the analgesic effect of HBO on neuropathic pain and decreased the expression of PKG1 mRNA and protein in the spinal dorsal horn J Headache Pain. 2017 Dec;18(1):51
Spontaneously hypertensive rats Spontaneously hypertensive rat model Intraperitoneal injection 30 mg/kg Single administration, lasting 6 hours To investigate the effect of L-NAME on the blood pressure-lowering effect of the peptide AVFQHNCQE. The results showed that L-NAME completely abolished the antihypertensive effect of AVFQHNCQE, indicating that its antihypertensive effect is mediated by changes in endothelium-derived NO availability. Nutrients. 2019 Jan 22;11(2):225
Wistar rats L-NAME-induced hypertension model Drinking water 40 mg/kg Once daily for four weeks To investigate the changes in cardiac function and the renin-angiotensin-aldosterone system in the L-NAME-induced hypertension model, and the protective effect of ivabradine. L-NAME increased systolic blood pressure and left ventricular weight, enhanced hydroxyproline concentration in the LV, and deteriorated LV function. Ivabradine reduced heart rate and systolic blood pressure, and improved LV function. Int J Mol Sci. 2018 Oct 3;19(10):3017

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.71mL

0.74mL

0.37mL

18.54mL

3.71mL

1.85mL

37.08mL

7.42mL

3.71mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories